| 000 | 01865 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517075605.0 | ||
| 264 | 0 | _c20170515 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1097-6809 | ||
| 024 | 7 |
_a10.1016/j.jvs.2014.11.088 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuang, Po-Hsun | |
| 245 | 0 | 0 |
_aSimvastatin pretreatment enhances ischemia-induced neovascularization and blood flow recovery in streptozotocin-treated mice. _h[electronic resource] |
| 260 |
_bJournal of vascular surgery _cOct 2016 |
||
| 300 |
_a1112-1120.e1 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlood Flow Velocity |
| 650 | 0 | 4 | _aCollateral Circulation |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xchemically induced |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xdrug therapy |
| 650 | 0 | 4 |
_aEndothelial Progenitor Cells _xdrug effects |
| 650 | 0 | 4 |
_aEzetimibe _xpharmacology |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aIschemia _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xmetabolism |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aRecovery of Function |
| 650 | 0 | 4 | _aRegional Blood Flow |
| 650 | 0 | 4 |
_aSimvastatin _xpharmacology |
| 650 | 0 | 4 | _aStreptozocin |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 700 | 1 | _aChen, Jian-You | |
| 700 | 1 | _aChen, Chi-Yu | |
| 700 | 1 | _aChen, Jaw-Wen | |
| 700 | 1 | _aLin, Shing-Jong | |
| 700 | 1 | _aShih, Chun-Che | |
| 773 | 0 |
_tJournal of vascular surgery _gvol. 64 _gno. 4 _gp. 1112-1120.e1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jvs.2014.11.088 _zAvailable from publisher's website |
| 999 |
_c25688520 _d25688520 |
||